This new route of administration is expected to become available during the fourth quarter of 2023.
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.
"A significant portion of the millions of PsA, AS, and nr-axSpA patients in the US require treatment through IV infusions for a variety of reasons, including not being comfortable with self-injections or simply preferring to have treatments administered in their healthcare provider's office," Philip J.
"With this approval of Cosentyx as an IV formulation, along with the subcutaneous formulation, we can broaden the use of Cosentyx to help more patients manage their condition with a medicine backed by more than a decade of clinical research and 8 years of real-world experience," said Christy Siegel, vice president and head of immunology, Novartis US.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA: Blood Pressure Medication Recall After Oxycodone FoundI am a writer, journalist, professor, systems modeler, computational, AI, and digital health expert, medical doctor, avocado-eater, and entrepreneur, not always in that order. Currently, I am a Professor of Health Policy and Management at the City University of New York (CUNY) School of Public Health, Executive Director of PHICOR (PHICORteam) and Center for Advanced Technology and Communication in Health (CATCH), and founder and CEO of Symsilico. My previous positions include serving as Profess
続きを読む »
FDA-approved injection can restore collagen and improve aging signsThe Food and Drug Administration has approved an easy and effective method of restoring collagen in the skin without having to ingest endless supplements.
続きを読む »
Alnylam to scrap sNDA for patisiran after receiving FDA complete response letterCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
続きを読む »
Alnylam Stock Is Dropping on Surprising FDA RejectionDrugmaker Alnylam wanted to expand approval of its drug Onpattro, but the Food and Drug Administration rejected the application even after an outside...
続きを読む »
FDA Adds Warning To Ozempic Label About Ileus, Intestinal BlockageI am a writer, journalist, professor, systems modeler, computational, AI, and digital health expert, medical doctor, avocado-eater, and entrepreneur, not always in that order. Currently, I am a Professor of Health Policy and Management at the City University of New York (CUNY) School of Public Health, Executive Director of PHICOR (PHICORteam) and Center for Advanced Technology and Communication in Health (CATCH), and founder and CEO of Symsilico. My previous positions include serving as Profess
続きを読む »
Novavax ships millions of updated COVID-19 vaccine doses after FDA clearanceVaccine manufacturer Novavax Inc. has announced the shipment of millions of doses of its updated COVID-19 vaccines to distributors following approval from U.S. regulators.
続きを読む »